TGM2 and irritable bowel syndrome: International guidelines suggest that tTG antibody tests (±EMA testing) should be preferred over AGAs (43-46) for the diagnosis of CD due to higher sensitivity and specificity of these tests, and one needs to consider the opportunistic screening of individuals with IBS using these serological tests for CD (44-46).